Using spatial phenotypic signatures to predict immunotherapy response

21 Apr 2021

In this infographic, discover how spatial phenotypic signatures can act as invaluable whole slide image-based quantitative biomarkers to predict immunotherapy response, and learn more about Akoya Biosciences’ comprehensive multiplex immunofluorescence solutions for spatial phenotyping.

PhenoImager® HT

Akoya Biosciences

PhenoImager ® HT (formerly Vectra ® Polaris™) is the fastest and most highly cited whole-slide, single-cell resolution imaging platform for spatial phenotyping and the development of spatial signatures. Featuring Akoya’s patented Multispectral Imaging (MSI) and spectral unmixing technologies, this platform can be easily integrated into high-throughput workflows to accommodate projects regardless of your scale. 

(2)

PhenoCycler®

Akoya Biosciences

The PhenoCycler ® is a cutting-edge fluidics control unit that integrates with the PhenoImager Fusion imaging platform creating the fastest spatial biology solution with unparalleled throughput. 

(3)

Links

Tags

Using spatial phenotypic signatures to predict immunotherapy response